Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
Evangelos Terpos, Karthik Ramasamy, Nadjoua Maouche, Jiří Minařík, Ioannis Ntanasis‐Stathopoulos, Eirini Katodritou, Matthew Jenner, Hana Plonková, Maria Gavriatopoulou, Grant Vallance, Tomáš Pika, Maria Kotsopoulou, Jaimal Kothari, Tomáš Jelı́nek, Efstathios Kastritis, Robin Aitchison, Meletios Α. Dimopoulos, Athanasios Zomas, Roman Hájek
Topics & Concepts
LenalidomideIxazomibMultiple myelomaDexamethasoneMedicineHematologyInternal medicineOncologyCarfilzomibMultiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsMyeloproliferative Neoplasms: Diagnosis and Treatment